Tocilizumab Injection Shortage
Last Updated: July 29, 2022
Status: Current
Reason for the Shortage
-
- Genentech has all Actemra presentations available.
Available Products
-
- Actemra intravenous solution for injection, Genentech, 20 mg/mL, 10 mL vial, NDC 50242-0136-01
- Actemra intravenous solution for injection, Genentech, 20 mg/mL, 20 mL vial, NDC 50242-0137-01
- Actemra intravenous solution for injection, Genentech, 20 mg/mL, 4 mL vial, NDC 50242-0135-01
- Actemra subcutaneous solution for injection, Genentech, 162 mg/0.9 mL, prefilled syringe, NDC 50242-0138-01
- Actemra ACTPen subcutaneous solution for injection, Genentech, 162 mg/0.9 mL, prefilled syringe, NDC 50242-0143-01
Alternative Agents & Management
-
- NIH has provided treatment options for hospitalized patients with Covid-19. These can be found at: https://www.covid19treatmentguidelines.nih.gov/management/clinical-management/hospitalized-adults--therapeutic-management/
Updated
Updated July 29, 2022 by Anthony Trovato, PharmD, BCPS. Created August 3, 2021 by Stephen Andrews, PharmD, BCPS, CPPS, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.